Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579462 · ClinicalTrials.gov registry record
Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 281
- Enrollment target
NCT00579462: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00579462 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 281 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579462 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 281 participants
- Enrollment target
Study Summary
The purpose of this study is to study whether the presence of lung cancer in your body can be detected by testing the blood, and if the results of these blood tests change as your tumor shrinks or grows.
Interventions
- OTHER Blood and Tissue studies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 281 participants |
| Start Date | 2003-01 |
| Est. Completion | 2010-11 |
What the finished NCT00579462 record still lists
NCT00579462 is an observational study that tracks outcomes without assigning an intervention. The registered 281 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blood and Tissue studies is the first listed.
NCT00579462 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00579462 about?
NCT00579462 is a clinical study titled "Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer". The purpose of this study is to study whether the presence of lung cancer in your body can be detected by testing the blood, and if the results of these blood tests change as your tumor shrinks or grows.
What is the current status of trial NCT00579462?
This trial is currently completed. The enrollment target is 281 participants. The study started on 2003-01. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00579462?
The interventions under investigation include: Blood and Tissue studies (OTHER).
Who is sponsoring clinical trial NCT00579462?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04521231 · 281 participants · Phase 1
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
- NCT06190730 · 281 participants · NA
REmote Symptom COllection to improVE postopeRative Care
- NCT02860364 · 282 participants · NA
Comparing Hypothermic Temperatures During Hemiarch Surgery
- NCT04867395 · 282 participants · NA
A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia